Biogen taps former Boston Scientific exec as next CFO
Four months after losing its longtime chief financial officer to another drugmaker, Biogen has appointed a former Boston Scientific executive to that post.
Cambridge-based Biogen (Nasdaq: BIIB) said Tuesday that Jeffrey Capello will take over as CFO on Dec. 11. He succeeds Paul Clancy, who served in that role for a decade before decamping for Alexion Pharmaceuticals (Nasdaq: ALXN) in July.
Capello has served for the past year as CFO of Beacon Heal th Options, a Boston-based behavioral health company.…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Max Stendahl Source Type: news
More News: Biotechnology | Health Management